KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Operating Leases (2021 - 2025)

Ionis Pharmaceuticals has reported Operating Leases over the past 5 years, most recently at $262.4 million for Q4 2025.

  • Quarterly results put Operating Leases at $262.4 million for Q4 2025, up 62.16% from a year ago — trailing twelve months through Dec 2025 was $262.4 million (up 62.16% YoY), and the annual figure for FY2025 was $262.4 million, up 62.16%.
  • Operating Leases for Q4 2025 was $262.4 million at Ionis Pharmaceuticals, roughly flat from $262.7 million in the prior quarter.
  • Over the last five years, Operating Leases for IONS hit a ceiling of $262.7 million in Q3 2025 and a floor of $19.4 million in Q4 2021.
  • Median Operating Leases over the past 5 years was $169.8 million (2023), compared with a mean of $172.0 million.
  • Biggest five-year swings in Operating Leases: surged 820.86% in 2022 and later fell 5.5% in 2025.
  • Ionis Pharmaceuticals' Operating Leases stood at $19.4 million in 2021, then surged by 820.86% to $178.9 million in 2022, then fell by 4.51% to $170.9 million in 2023, then decreased by 5.31% to $161.8 million in 2024, then soared by 62.16% to $262.4 million in 2025.
  • The last three reported values for Operating Leases were $262.4 million (Q4 2025), $262.7 million (Q3 2025), and $164.4 million (Q2 2025) per Business Quant data.